1887

Abstract

The aim of this study was to assess the epidemiology and molecular basis of the infection and dissemination of multidrug-resistant (MDRAB) in three sequential outbreaks at the intensive care units (ICUs) of a tertiary university hospital in Granada, Spain, between 2009 and 2011. Strains from all patients infected and/or colonized by MDRAB during outbreak periods were characterized using PFGE and multilocus sequence typing (MLST). The first outbreak appeared in the summer of 2009 involving 38 ICU patients: 25 from a Traumatology–Rehabilitation hospital (TRH) and 13 from a Medical–Surgery hospital (MSH). Between 2010 and 2011, outbreaks were limited to the MSH-ICU, affecting 9 and 11 patients, respectively. Two PFGE types were detected. In the 2009 outbreak, two clones were identified: profile 1 strains were isolated at the TRH, whilst profile 2 was isolated at the MSH. Only one clone was identified in the 2010 and 2011 outbreaks: the profile 2 clone detected at the MSH in 2009. After MLST analysis, a single sequence type (ST92) was identified. This suggested that an endemic strain could evolve and cause localized outbreaks in vulnerable patients. Multiplex PCR for OXA group enzymes yielded a positive result for and genes, and gene sequencing showed the presence of . However, the absence of IS upstream of the gene suggested the absence of OXA-51 expression. The susceptibility pattern was not an appropriate method for MDRAB surveillance, as several susceptibility patterns were identified in a single clone. Consequently, molecular methods of characterization are recommended for epidemiological surveillance of MDRAB.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.067280-0
2014-08-01
2019-12-08
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/8/1093.html?itemId=/content/journal/jmm/10.1099/jmm.0.067280-0&mimeType=html&fmt=ahah

References

  1. Adams-Haduch J. M. , Onuoha E. O. , Bogdanovich T. , Tian G. B. , Marschall J. , Urban C. M. , Spellberg B. J. , Rhee D. , Halstead D. C. et al. ( 2011; ). Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. . J Clin Microbiol 49:, 3849–3854. [CrossRef] [PubMed]
    [Google Scholar]
  2. Bartual S. G. , Seifert H. , Hippler C. , Luzon M. A. , Wisplinghoff H. , Rodríguez-Valera F. . ( 2005; ). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii . . J Clin Microbiol 43:, 4382–4390. [CrossRef] [PubMed]
    [Google Scholar]
  3. CLSI ( 2011; ). Performance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement M100-S21. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  4. Endo S. , Yano H. , Hirakata Y. , Arai K. , Kanamori H. , Ogawa M. , Shimojima M. , Ishibashi N. , Aoyagi T. et al. ( 2012; ). Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. . J Antimicrob Chemother 67:, 1623–1626. [CrossRef] [PubMed]
    [Google Scholar]
  5. Fernández-Cuenca F. , Pascual A. , Ribera A. , Vila J. , Bou G. , Cisneros J. M. , Rodríguez-Baño J. , Pachón J. , Martínez-Martínez L. . Grupo de Estudio de Infección Hospitalaria ( 2004; ). Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000). . Enferm Infecc Microbiol Clin 22:, 267–271 (in Spanish).[PubMed] [CrossRef]
    [Google Scholar]
  6. Garner J. S. , Jarvis W. R. , Emori T. G. , Horan T. C. , Hughes J. M. . ( 1988; ). CDC definitions for nosocomial infections, 1988. . Am J Infect Control 16:, 128–140. [CrossRef] [PubMed]
    [Google Scholar]
  7. Jawad A. , Hawkey P. M. , Heritage J. , Snelling A. M. . ( 1994; ). Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton’s agar. . J Clin Microbiol 32:, 2353–2358.[PubMed]
    [Google Scholar]
  8. Lopes B. S. , Evans B. A. , Amyes S. G. . ( 2012; ). Disruption of the bla OXA-51-like gene by ISAba16 and activation of the bla OXA-58 gene leading to carbapenem resistance in Acinetobacter baumannii Ab244. . J Antimicrob Chemother 67:, 59–63. [CrossRef] [PubMed]
    [Google Scholar]
  9. Magiorakos A. P. , Srinivasan A. , Carey R. B. , Carmeli Y. , Falagas M. E. , Giske C. G. , Harbarth S. , Hindler J. F. , Kahlmeter G. et al. ( 2012; ). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. . Clin Microbiol Infect 18:, 268–281. [CrossRef] [PubMed]
    [Google Scholar]
  10. Marqué S. , Poirel L. , Héritier C. , Brisse S. , Blasco M. D. , Filip R. , Coman G. , Naas T. , Nordmann P. . ( 2005; ). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. . J Clin Microbiol 43:, 4885–4888. [CrossRef] [PubMed]
    [Google Scholar]
  11. Mugnier P. D. , Poirel L. , Naas T. , Nordmann P. . ( 2010; ). Worldwide dissemination of the bla OXA-23 carbapenemase gene of Acinetobacter baumannii . . Emerg Infect Dis 16:, 35–40. [CrossRef] [PubMed]
    [Google Scholar]
  12. Nigro S. J. , Hall R. M. . ( 2012; ). Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate. . J Antimicrob Chemother 67:, 1342–1346. [CrossRef] [PubMed]
    [Google Scholar]
  13. Ruiz M. , Marti S. , Fernandez-Cuenca F. , Pascual A. , Vila J. . ( 2007; ). High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. . Clin Microbiol Infect 13:, 1192–1198. [CrossRef] [PubMed]
    [Google Scholar]
  14. Rumbo C. , Gato E. , López M. , Ruiz de Alegría C. , Fernández-Cuenca F. , Martínez-Martínez L. , Vila J. , Pachón J. , Cisneros J. M. et al. ( 2013; ). Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii . . Antimicrob Agents Chemother 57:, 5247–5257. [CrossRef] [PubMed]
    [Google Scholar]
  15. Seifert H. , Dolzani L. , Bressan R. , van der Reijden T. , van Strijen B. , Stefanik D. , Heersma H. , Dijkshoorn L. . ( 2005; ). Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii . . J Clin Microbiol 43:, 4328–4335. [CrossRef] [PubMed]
    [Google Scholar]
  16. Sevillano E. , Fernández E. , Bustamante Z. , Zabalaga S. , Rosales I. , Umaran A. , Gallego L. . ( 2012; ). Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia. . J Med Microbiol 61:, 80–84. [CrossRef] [PubMed]
    [Google Scholar]
  17. Tacconelli E. , Cataldo M. A. , Dancer S. J. , De Angelis G. , Falcone M. , Frank U. , Kahlmeter G. , Pan A. , Petrosillo N. et al. ( 2014; ). ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. . Clin Microbiol Infect 20: (Suppl 1), 1–55. [CrossRef] [PubMed]
    [Google Scholar]
  18. Tenover F. C. , Arbeit R. D. , Goering R. V. , Mickelsen P. A. , Murray B. E. , Persing D. H. , Swaminathan B. . ( 1995; ). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. . J Clin Microbiol 33:, 2233–2239.[PubMed]
    [Google Scholar]
  19. Turton J. F. , Ward M. E. , Woodford N. , Kaufmann M. E. , Pike R. , Livermore D. M. , Pitt T. L. . ( 2006; ). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii . . FEMS Microbiol Lett 258:, 72–77. [CrossRef] [PubMed]
    [Google Scholar]
  20. Woodford N. , Ellington M. J. , Coelho J. M. , Turton J. F. , Ward M. E. , Brown S. , Amyes S. G. , Livermore D. M. . ( 2006; ). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. . Int J Antimicrob Agents 27:, 351–353. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.067280-0
Loading
/content/journal/jmm/10.1099/jmm.0.067280-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error